换一批
换一批Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3.
作者：
主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞系, 肿瘤(Cell Line, Tumor);细胞存活(Cell Survival);药物协同作用(Drug Synergism);基因敲低技术(Gene Knockdown Techniques);组蛋白脱乙酰基酶抑制剂(Histone Deacetylase Inhibitors);人类(Humans);羟肟酸类(Hydroxamic Acids);吲哚类(Indoles);男(雄)性(Male);黑色素瘤(Melanoma);小鼠(Mice);小鼠, 裸(Mice, Nude);突变, 误义(Mutation, Missense);坏死(Necrosis);原癌基因蛋白质B-raf(Proto-Oncogene Proteins B-raf);RNA, 小分子干扰(RNA, Small Interfering);受体作用蛋白丝氨酸苏氨酸激酶类(Receptor-Interacting Protein Serine-Threonine Kinases);磺胺类(Sulfonamides);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1038/cddis.2013.192
PMID
23744355
发布时间
2021-10-21
- 浏览2
Cell death & disease
e655页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
